Wilmington Savings Fund Society’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Buy |
39,573
+3,711
| +10% | +$62.2K | 0.01% | 519 |
|
|
2025
Q1 | $551K | Buy |
35,862
+7,012
| +24% | +$108K | 0.01% | 557 |
|
|
2024
Q4 | $636K | Buy |
28,850
+26,091
| +946% | +$575K | 0.01% | 524 |
|
|
2024
Q3 | $49.7K | Buy |
+2,759
| New | +$49.7K | ﹤0.01% | 1222 |
|
|
2016
Q4 | – | Sell |
-8,890
| Closed | -$409K | – | 334 |
|
|
2016
Q3 | $409K | Buy |
8,890
+225
| +3% | +$10.4K | 0.03% | 250 |
|
|
2016
Q2 | $435K | Buy |
8,665
+2,989
| +53% | +$150K | 0.03% | 248 |
|
|
2016
Q1 | $303K | Sell |
5,676
-249
| -4% | -$13.3K | 0.02% | 273 |
|
|
2015
Q4 | $389K | Buy |
5,925
+300
| +5% | +$19.7K | 0.02% | 260 |
|
|
2015
Q3 | $317K | Hold |
5,625
| – | – | 0.02% | 271 |
|
|
2015
Q2 | $333K | Buy |
5,625
+535
| +11% | +$31.7K | 0.02% | 281 |
|
|
2015
Q1 | $317K | Sell |
5,090
-1,693
| -25% | -$105K | 0.02% | 284 |
|
|
2014
Q4 | $390K | Sell |
6,783
-475
| -7% | -$27.3K | 0.02% | 277 |
|
|
2014
Q3 | $390K | Hold |
7,258
| – | – | 0.02% | 280 |
|
|
2014
Q2 | $380K | Sell |
7,258
-1,015
| -12% | -$53.1K | 0.02% | 298 |
|
|
2014
Q1 | $438K | Buy |
8,273
+2,748
| +50% | +$145K | 0.02% | 286 |
|
|
2013
Q4 | $221K | Sell |
5,525
-4,567
| -45% | -$183K | 0.01% | 357 |
|
|
2013
Q3 | $381K | Buy |
10,092
+590
| +6% | +$22.3K | 0.02% | 294 |
|
|
2013
Q2 | $372K | Buy |
+9,502
| New | +$372K | 0.02% | 291 |
|